Discovery of Novel CYP17 Inhibitors for the Treatment of Prostate Cancer with Structure-Based Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|6|5|337-344

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.6, Iss.5, 2009-07, pp. : 337-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 2, 2014-07 ,pp. : 131-138

Bentham Science Publishers

Access to resources Recommend Favorite

CYP17 Inhibitors for Prostate Cancer Treatment - An Update

By  

Current Medicinal Chemistry, Vol. 15, Iss. 9, 2008-04 ,pp. : 868-899

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-04 ,pp. : 901-916

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Novel HDAC Inhibitors by Structure-based Optimization of Cinnamic Hydroxamic Scaffold

By  

Letters in Drug Design & Discovery, Vol. 12, Iss. 5, 2015-06 ,pp. : 344-350

Bentham Science Publishers

Access to resources Recommend Favorite